What is it about?
Despite major breakthroughs in medicine, cancer remains a leading cause of illness and death across the globe. One of the biggest challenges doctors face is that cancer cells frequently build up a resistance to standard treatments like chemotherapy. When this happens, therapies fail and patient outcomes worsen. This review article breaks down the exact cellular and molecular tricks cancer cells use to survive treatments. It also highlights cutting-edge counter-strategies—such as advanced nanotechnology, combination drug cocktails, and gene-editing tools—designed to shatter these defense barriers, maximize the power of chemotherapy, and ultimately save more lives.
Featured Image
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Why is it important?
Monotherapy often triggers cancer cells to activate alternative survival pathways, accelerating drug resistance. This paper is unique because it moves beyond purely abstract theories by incorporating concrete patent data and structural case studies. It details distinct tactical solutions to bypass cellular armor. These solutions include surface-modified nanocarriers that sneak medications past defense pumps, specialized therapies that block a tumor’s glucose energy supply, and adaptive "on-and-off" dosing schedules that use natural cellular competition to delay resistance. Laying out these interconnected mechanisms helps researchers and clinicians design more effective, personalized treatment protocols to lower cancer mortality.
Perspectives
Writing this comprehensive review allowed our team to bridge the gap between complex tumor biology and clinical reality. Cancer cells adapt and alter their properties daily to evade destruction, making standard single-drug chemotherapy increasingly difficult to rely on alone. By compiling the latest breakthroughs in nanotechnology, CRISPR genetics, and smart dosing strategies, we wanted to map out a clear path forward. We hope this paper inspires closer collaboration between pharmaceutical chemists and oncologists to turn these targeted approaches into real-world bedside treatments
Mr. Siddharth .
Noida Institute of Engineering and Technology Pharmacy Institute
Read the Original
This page is a summary of: Unveiling Targeted Approaches to Combat Drug Resistance in Cancer Chemotherapy, Current Pharmaceutical Design, March 2026, Bentham Science Publishers,
DOI: 10.2174/0113816128380235250627143945.
You can read the full text:
Resources
Contributors
The following have contributed to this page
